Glenmark Pharma Inks Deal With MeyerZall Labs (India)
This article was originally published in PharmAsia News
Executive Summary
Glenmark Pharmaceuticals Ltd, one of India's biggest pharmaceutical companies, is teaming up with the South Africa-based MeyerZall Laboratories. The deal stretches for a period of 10 years. Over that time the two companies will work together to expand drugs in Glenmark's topical dermatology pipeline. These treatments will primarily focus on aiding patients suffering from psoriasis, fungal infections, and inflammation. Thanks to the new partnership, Glenmark and MeyerZall will be able to offer the largest range of topical dermatology products in South Africa. (Click here for more